Is It Safe to Take Tylenol During Pregnancy?

If you’re pregnant and dealing with a headache, fever, or body aches, you’ve probably reached for Tylenol at some point. It’s been the go-to pain reliever during pregnancy for decades. But recent research has sparked new questions about whether acetaminophen, the active ingredient in Tylenol, might affect your baby’s development.

The conversation around acetaminophen use during pregnancy has become more complicated. Some studies suggest potential links to developmental concerns, while others find no connection at all. Meanwhile, leaving fever and pain untreated carries its own documented risks.

If you are reading this article, you are likely pregnant and curious about which medications are safe during pregnancy. That’s a good thing. Never assume things, always do your research, and never be ashamed to reach out to your doctor. Your health, and your child’s health depend on your prudence.

This article breaks down what the current research actually shows, what health agencies are saying, and how to make an informed decision about pain and fever management during pregnancy.

How Common Is Tylenol Use During Pregnancy?

You’re not alone if you’ve taken acetaminophen (most commonly available as Tylenol) while pregnant. Between 50% and 65% of pregnant women in the United States use it at least once during their pregnancy. Globally, that number sits above 50%.

Most women who use acetaminophen during pregnancy take it for short periods. Among U.S. users, 58% reported using it for less than 10 days, while only 9% used it for 45 days or longer. The most common reasons include headaches, pain from injuries, arthritis, sleep issues, and fever.

In Denmark, acetaminophen prescriptions during pregnancy increased by 47% between 2015 and 2023, with 76 out of every 1,000 pregnant women filling a prescription.

What the FDA Said in September 2025 About Acetaminophen and Pregnancy

On September 21, 2025, the FDA announced it would begin changing acetaminophen labels to reflect emerging evidence about potential risks during pregnancy. This announcement got a lot of attention and raised concerns among pregnant women nationwide.

Here’s what the FDA actually said:

The evidence shows a correlation, not causation. Some studies have found associations between acetaminophen use during pregnancy and diagnoses of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children, particularly with chronic use throughout pregnancy. But the FDA was clear that a causal relationship has not been established.

The science is still debated. There are studies showing contrary findings, and researchers continue to investigate this question.

Acetaminophen remains the safest over-the-counter option. The FDA stated that among all pain relievers and fever reducers available without a prescription, acetaminophen is still the safest choice during pregnancy. Alternatives like aspirin and ibuprofen have well-documented adverse effects on fetal development.

Use should be minimized for routine low-grade fevers. The FDA urged doctors to consider whether acetaminophen is truly necessary for minor fevers during pregnancy.

The agency issued a nationwide notice to healthcare providers to alert them of this evolving area of research.

Current Guidelines from Major Medical Organizations

What ACOG Says About Acetaminophen Use

The American College of Obstetricians and Gynecologists reaffirmed its position in August and September 2025: acetaminophen remains the analgesic and antipyretic of choice during pregnancy.

ACOG’s guidance emphasizes:

• Use at the lowest effective dose for the shortest necessary duration
• Current evidence does not support a causal link between prenatal acetaminophen and neurodevelopmental disorders
• Untreated fever, pain, and headaches pose greater risks than acetaminophen use
• No change in clinical practice is warranted based on recent publications

ACOG specifically notes that severe headaches can signal preeclampsia, a dangerous pregnancy complication that requires immediate medical attention.

CDC and NIH Position on Acetaminophen During Pregnancy

The Centers for Disease Control and Prevention continues to list acetaminophen as the recommended medication for pain and fever management during pregnancy, especially for high fever, which poses documented risks to fetal development.

The National Institutes of Health funded a major 2024 study in Sweden that followed 2.48 million children and found no causal link between acetaminophen exposure during pregnancy and autism, ADHD, or intellectual disability when researchers controlled for genetic and family factors.

The CDC emphasizes something critical: untreated maternal fever, particularly in the first trimester, increases risks of neural tube defects, miscarriage, preterm birth, and developmental issues.

Research Showing Associations Between Acetaminophen and Developmental Outcomes

Several studies have identified statistical associations between prenatal acetaminophen use and neurodevelopmental diagnoses. Association means these things occur together more often than expected by chance, but it doesn’t prove that one causes the other.

Mount Sinai and Harvard Meta-Analysis

A 2025 systematic review examined 46 studies worldwide involving more than 100,000 participants. Twenty-seven of these studies showed positive associations with neurodevelopmental disorders. Interestingly, higher-quality studies were more likely to show positive associations.

The review found that associations were strongest when acetaminophen was taken for four or more weeks during pregnancy. The researchers recommended judicious use at the lowest effective dose for the shortest duration under medical guidance.

The proposed biological mechanisms include:

• Acetaminophen crosses the placental barrier
• May trigger oxidative stress in fetal tissues
• Could disrupt hormones involved in brain development
• Might cause epigenetic changes that affect how genes are expressed during fetal brain development

Boston Birth Cohort Study With Cord Blood Measurements

A 2020 study took a different approach by measuring acetaminophen metabolites directly in cord blood at birth rather than relying on mothers’ recall of medication use. The study followed 996 mother-infant pairs prospectively.

Acetaminophen was detected in the cord plasma of 17% of newborns. Higher cord acetaminophen levels were associated with up to three times increased risk for ADHD and ASD diagnoses in a dose-response pattern, meaning higher exposure correlated with higher risk.

This study is notable because it measured actual fetal exposure rather than depending on maternal self-reporting, which can be unreliable.

Placental Epigenetic Changes

A 2019 NIH-funded study found that maternal acetaminophen use was associated with changes in DNA methylation at 42 sites in placental tissue. DNA methylation is one way genes are turned on or off without changing the underlying DNA sequence.

Some of these changes occurred in the PTGDR gene, which codes for a prostaglandin receptor essential for placental blood flow and fetal growth. The study also observed sex-specific effects, with some methylation changes appearing only in male placentas and others only in female placentas.

Research Showing No Link Between Acetaminophen and Developmental Disorders

Not all research supports the association between prenatal acetaminophen use and neurodevelopmental outcomes. Some of the largest and most rigorous studies have found no connection.

Swedish Population Study of 2.48 Million Children

Published in JAMA in 2024, this study examined birth and health records of 2.48 million children born in Sweden between 1995 and 2019. It’s the largest study on this topic to date.

When researchers compared siblings within the same families, they found no evidence of increased risk:

• Autism: hazard ratio of 0.98 (essentially no difference)
• ADHD: hazard ratio of 0.98 (essentially no difference)
• Intellectual disability: hazard ratio of 1.01 (essentially no difference)

The associations that appeared in standard analyses disappeared when sibling controls were used. This suggests that what earlier studies identified as a medication effect might actually be due to familial confounding, meaning shared genetics, parental health conditions, or environmental exposures that run in families.

This study was funded by the NIH’s National Institute of Neurological Disorders and Stroke and represents a major U.S. and Swedish research collaboration.

BMJ Umbrella Review From November 2025

The most recent comprehensive review, published in the British Medical Journal in November 2025, examined nine systematic reviews covering all relevant studies published through September 30, 2025.

The conclusion: the quality and validity of current evidence does not support a causal relationship between maternal acetaminophen use during pregnancy and autism or ADHD.

The researchers noted that the Trump administration’s September warnings caused considerable concern among pregnant women worldwide. Regulatory agencies in the UK, European Union, and Australia responded by reassuring pregnant women based on their own evidence reviews.

Why Do Study Results Differ So Much?

You might be wondering how studies on the same topic can reach such different conclusions. Several factors explain these discrepancies:

Study design matters enormously. Observational studies that simply compare women who used acetaminophen to those who didn’t are vulnerable to confounding. Women who take acetaminophen during pregnancy may differ from those who don’t in ways that affect their children’s outcomes, like having more pain conditions, infections, or inflammation.

Sibling comparison studies control for genetics and shared family environment. When researchers compare siblings within the same family where one was exposed to acetaminophen prenatally and one wasn’t, they automatically control for genetics, parenting styles, socioeconomic factors, and many other confounders. The Swedish study’s use of sibling controls is why it’s considered particularly robust.

Recall bias affects self-reported medication use. When mothers are asked years later what medications they took during pregnancy, memory may not be accurate. Parents of children with developmental diagnoses might remember and report medication use differently than parents of typically developing children.

Confounding by indication is a major challenge. This means the reason someone takes medication might be the actual risk factor, not the medication itself. For example, if maternal illness, inflammation, or infection increases developmental risk, studies might wrongly attribute the risk to the acetaminophen taken to treat those conditions.

What Does Untreated Fever Do to Fetal Development?

While researchers debate potential acetaminophen risks, the dangers of untreated maternal fever are well-established and not in question.

The CDC’s National Birth Defects Prevention Study found that maternal fever during early pregnancy significantly increased the risk of eight birth defects:

• Anencephaly
• Spina bifida
• Encephalocele
• Cleft lip with or without cleft palate
• Colonic atresia
• Bilateral renal agenesis
• Limb reduction defects
• Gastroschisis

The adjusted odds ratios ranged from 1.2 to 3.7, depending on the specific defect. About 6% to 8% of early pregnancies involve maternal fever at some point.

Importantly, having a cold or flu without fever was not associated with birth defects, suggesting that fever itself, not the underlying illness, drives the excess risk. The mechanism likely involves hyperthermia affecting critical developmental processes during sensitive periods of organ formation.

Additional documented risks of untreated fever include:

• Neural tube defects with the highest risk in the first trimester
• Increased miscarriage risk
• Preterm birth, with growing evidence for fever later in pregnancy
• Potential impacts on fetal brain development from sustained elevated maternal temperature

What Does Untreated Pain Do During Pregnancy?

Pain isn’t just uncomfortable. Untreated pain during pregnancy can have real consequences:

Mental health impacts. Chronic pain increases risk of depression and anxiety during pregnancy. Maternal mental health affects fetal development and pregnancy outcomes.

Stress hormone effects. Unmanaged pain elevates stress hormones like cortisol, which cross the placenta and can negatively affect fetal development.

Cardiovascular effects. Pain contributes to elevated blood pressure, which can become dangerous during pregnancy.

Missed warning signs. Severe headaches can signal preeclampsia, a potentially life-threatening condition. Pain that prevents you from noticing or reporting severe headaches could delay critical diagnosis.

Safe Acetaminophen Dosing Guidelines for Pregnancy

If you and your healthcare provider decide that acetaminophen is appropriate, using it safely involves following dosage and duration guidelines.

Maximum Recommended Doses

The general adult maximum is 4,000 mg per 24 hours, but pregnancy guidelines are more conservative:

Recommended pregnancy maximum: 3,000 mg per 24 hours, divided into smaller doses

For regular strength tablets (325 mg):

• Take 1 to 2 tablets every 4 to 6 hours
• Maximum of 10 tablets per day

For extra strength tablets (500 mg):

• Take 1 to 2 tablets every 6 hours
• Maximum of 6 tablets per day

For acute migraine (per ACOG guidelines):

• Up to 1,000 mg up to three times per day

Duration and Frequency Recommendations

Use acetaminophen as needed, not on a daily schedule unless your doctor specifically recommends it. Take it for the shortest duration necessary to manage your symptoms.

Avoid prolonged or chronic use, generally defined as more than four weeks of regular use. If you need pain or fever relief for an extended period, discuss alternatives and underlying causes with your healthcare provider.

Always consult your doctor before starting or continuing acetaminophen during pregnancy, even though it’s available over the counter.

Trimester-Specific Considerations

First trimester: Use cautiously, as this is when organ systems form. However, untreated fever during this period poses the highest risk of neural tube defects and other birth defects, so treating high fever is important.

Second trimester: Generally considered safe for symptom management. Some research suggests second-trimester exposure may have greater impact on testicular and reproductive development in male fetuses.

Third trimester: Safe for maternal pain and fever management, though some evidence suggests chronic use during this period may have the strongest association with neurodevelopmental outcomes in studies showing associations.

What Acetaminophen Is Recommended For

Healthcare providers recommend acetaminophen during pregnancy for:

• High fever, particularly 101°F or higher
• Headaches, including migraines (after ruling out preeclampsia)
• Back pain, a common pregnancy complaint
• Pain from injuries or accidents
• Arthritis pain
• Labor and delivery pain, both vaginal and cesarean

When to Avoid Acetaminophen or Use Extra Caution

Certain conditions require avoiding acetaminophen or using lower doses under close medical supervision:

• Liver disease or impaired liver function
• Kidney disease or impaired kidney function
• Conditions requiring reduced medication doses

Avoiding Accidental Overdose

Many over-the-counter cold and flu remedies contain acetaminophen, often in combination with other ingredients. Check labels carefully. Common combination products include:

• Multi-symptom cold and flu medications
• Nighttime sleep aids with pain relief
• Sinus medications
• Some prescription pain medications

Your total acetaminophen intake from all sources counts toward your daily maximum. Taking multiple products containing acetaminophen can lead to accidental overdose.

Never combine acetaminophen with alcohol. Avoid taking it with other acetaminophen-containing products.

Signs of Acetaminophen Overdose

Overdose can cause liver damage, kidney damage, and anemia in the pregnant person. Potential fetal harm can also occur.

Seek immediate medical attention if you experience:

• Nausea or vomiting
• Loss of appetite
• Confusion or unusual behavior
• Stomach pain
• Yellowing of skin or eyes
• Dark urine
• Unusual fatigue

Proposed Biological Mechanisms for Developmental Effects

Researchers investigating potential acetaminophen effects on fetal development have identified several possible biological pathways, though none are definitively proven to cause the outcomes seen in some studies.

Endocrine Disruption Properties

Acetaminophen has known endocrine-disrupting properties, meaning it can interfere with hormone systems. Proposed effects include:

• Disruption of sex hormones important for fetal development
• Possible links to early puberty in girls in some studies
• Potential impacts on male fertility, including lower sperm counts in adulthood
• Association with undescended testicles and hypospadias in some research

Prostaglandin Pathway Disruption

Acetaminophen works partly by affecting prostaglandin synthesis. Prostaglandins are hormone-like substances critical for:

• Placental blood flow
• Hormone regulation during pregnancy
• Fetal growth
• Labor initiation

Disrupting these pathways could theoretically affect multiple aspects of fetal development.

Oxidative Stress and Epigenetic Changes

Laboratory and animal studies suggest acetaminophen might:

• Increase oxidative stress in fetal tissues
• Alter DNA methylation patterns that control gene expression
• Affect critical developmental signaling pathways like Wnt and Notch
• Influence fetal brain development through hormonal or inflammatory mechanisms

The dose-response relationships observed in cord blood studies, where higher exposure correlates with higher risk, support the biological plausibility of these mechanisms. However, correlation in human studies doesn’t prove these mechanisms actually operate in the way laboratory studies suggest.

Questions to Discuss With Your Healthcare Provider

Every pregnancy is different, and your medical history, current symptoms, and individual risk factors all matter. Here are questions to raise with your doctor or midwife:

About your specific situation:

• Do I have a medical condition that affects how I should use acetaminophen?
• What are the risks of leaving my current symptoms (fever/pain) untreated?
• Are there non-medication approaches that might help my symptoms?
• If I need acetaminophen, what’s the lowest effective dose for my situation?

About timing and duration:

• How long can I safely use acetaminophen for my current issue?
• Are there particular weeks or trimesters when I should be more or less cautious?
• At what point should I contact you if symptoms aren’t improving?

About alternatives:

• Are there other pain or fever management options appropriate for my situation?
• What symptoms warrant treating with medication versus managing with other approaches?
• Are there any prescription options that might be safer or more effective for chronic issues?

Making an Informed Decision About Acetaminophen Use

The research landscape on acetaminophen and pregnancy is genuinely mixed. You’re not dealing with clear-cut answers, and that’s frustrating when you’re trying to make the best choice for your baby.

Here’s what we know with confidence: Untreated high fever during pregnancy, especially in early pregnancy, carries documented risks of birth defects and pregnancy complications. Chronic, unmanaged pain can affect your mental health, stress levels, and blood pressure. Acetaminophen remains the safest over-the-counter pain and fever reducer available during pregnancy, with alternatives, such as medical cannabis and other NSAIDS like naproxen and ibuprofen carrying known risks.

The evidence for neurodevelopmental effects is inconsistent. The largest, most methodologically rigorous study found no causal link when genetic and family factors were controlled. Other studies show associations that may reflect confounding factors rather than direct medication effects. The FDA acknowledges that causation hasn’t been established.

If you need acetaminophen, using it judiciously at the lowest effective dose for the shortest necessary duration appears to be the most prudent approach. Avoid chronic, prolonged use unless medically necessary. Reserve it for symptoms that genuinely warrant treatment, particularly high fever and pain that affects your functioning or wellbeing. Stay in close communication with your healthcare provider, especially if you need symptom management over an extended period.